A Phase 2b study of TAK-755 (rADAMTS13) with minimal to no PEX in the treatment of patients with iTTP

Project: Research project

Project Details

Description

A Phase 2b study of TAK-755 (rADAMTS13) with minimal to no PEX in the treatment of patients with iTTP
StatusActive
Effective start/end date1/5/23 → 6/30/26

Funding

  • TAKEDA DEVELOPMENT CENTER AMERICAS, INC.